Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Lin Xu
In chronic kidney disease (CKD) patients, vascular calcification (VC) and cardiac valve calcification (CVC) are the major reasons of increased risk of cardiovascular events. Originally thought to be a passive kind of dead or dying cells, VC and CVC have since been identified as a disease caused by an active and highly controlled cellular process. Several of the processes implicated in VC have recently been identified, and many of them may be exacerbated in CKD patients. FGF-23/Klotho axis, Wnt pathways, PI3K/Akt signalling, P38MAPK signalling pathway, and microRNAs, in particular, have been demonstrated to be disturbed in CKD patients and may have a role in vascular calcification. Moreover, multiple researches confirmed the hazards of CVC in CKD patients as well as the molecular processes behind it. The purpose of this review is to describe the risk variables and pathophysiological processes that may be implicated in the relationship among CKD and VC and CVC development.